Aureobasidium.org

Review 2015

Molecular Interactions of β-(1→3)-Glucans with Their Receptors

Legentil, Laurent; Paris, Franck; Ballet, Caroline; Trouvelot, Sophie; Daire, Xavier; Vetvicka, Vaclav; Ferrières, Vincent · Molecules · DOI: 10.3390/molecules20069745
Research Archive
TL;DR — Key Findings
  • The review covers Dectin-1, CR3, glycolipids, langerin, and carbohydrate-binding modules.
  • Beta-glucan recognition depends on structural and physicochemical properties.
  • It does not demonstrate superior receptor binding or clinical potency for AP-glucan.

Abstract

This review describes molecular recognition of beta-1,3-glucans by human, animal, and microbial receptors. It covers immune receptors including Dectin-1 and complement receptor 3, as well as glycolipids, langerin, and carbohydrate-binding modules involved in binding or degradation. The authors emphasize that responses depend on characteristics such as molecular weight, branching, conformation, and solubility, and that several recognition mechanisms remain incompletely understood. The article is a mechanistic review and does not compare clinical outcomes or establish the potency of any particular commercial beta-glucan.

Summary

Summary

Scope

A mechanistic review of beta-1,3-glucan interactions with immune and carbohydrate-binding receptors.

Interpretation

Receptor binding varies with glucan structure. The review does not rank products or demonstrate clinical benefit.

AI-generated summary for accessibility. Always refer to the original paper.

Citation

Legentil, Laurent; Paris, Franck; Ballet, Caroline; Trouvelot, Sophie; Daire, Xavier; Vetvicka, Vaclav; Ferrières, Vincent. Molecular Interactions of β-(1→3)-Glucans with Their Receptors. Molecules. 2015. DOI: 10.3390/molecules20069745.

Study Details
Study Type
Review
Published
2015
Journal
Molecules
Authors
Legentil, Laurent; Paris, Franck; Ballet, Caroline; Trouvelot, Sophie; Daire, Xavier; Vetvicka, Vaclav; Ferrières, Vincent
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.